Literature DB >> 7273483

Analysis of the peanut agglutinin-binding site as a differentiation marker of normal and malignant human lymphoid cells.

U Galili, N Galili, R Or, A Polliack.   

Abstract

The lectin peanut agglutinin (PNA), which interacts specifically with D-galactosyl residues, was studied for its binding to human normal and malignant lymphoid cells at various stages of differentiation. As previously reported, PNA binds to thymocytes; however, it does not interact with the prothymocytes which precede the cortical thymocyte differentiation stage. No mature peripheral cells in any of the lymphoid organs bind PNA. In contrast to the normal T differentiation pathway, the expression of the PNA-binding site does not seem to coincide with that of T cell characteristics in the various malignant lymphoid cells studied. We therefore conclude that more information is needed about the nature of the PNA-binding site before it can be used as a differentiation marker in malignant lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273483      PMCID: PMC1537290     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Sialic acids and sialyltransferases in murine lymphoid cells: indicators of T cell maturation.

Authors:  J P Despont; C A Abel; H M Grey
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

3.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

4.  Effect of neuraminidase on lymphoid cells. Differences in structure of B and T cells and thymocytes of the mouse shown by cell electrophoresis and sialic acid determination.

Authors:  J N Wiig
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

5.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

6.  The Sezary cell: cytologic, cytochemical, and immunologic studies.

Authors:  G Flandrin; J C Brouet
Journal:  Mayo Clin Proc       Date:  1974-08       Impact factor: 7.616

7.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

8.  Fractionation of immunocompetent cells by free-flow cell electrophoresis.

Authors:  P Häyry; L C Andersson; C Gahmberg; P Roberts; A Ranki; S Nordling
Journal:  Isr J Med Sci       Date:  1975-12

9.  Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment.

Authors:  A Novogrodsky; R Lotan; A Ravid; N Sharon
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

10.  The effect of neuraminidase on the fate of transfused lymphocytes.

Authors:  J J Woodruff; B M Gesner
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

View more
  4 in total

1.  Bone marrow engraftment efficiency is enhanced by competitive inhibition of the hepatic asialoglycoprotein receptor.

Authors:  W E Samlowski; R A Daynes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  The use of lectins to study normal differentiation and malignant transformation.

Authors:  A Raedler; E Raedler
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Thymosin beta 4 induced phenotypic changes in Molt-4 leukemic cell line.

Authors:  D Kokkinopoulos; S Perez; M Papamichail
Journal:  Blut       Date:  1985-06

4.  Peanut agglutinin: a marker for normal and leukaemic cells of the monocyte lineage.

Authors:  D O'Keefe; L Ashman
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.